Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 184
Filter
1.
What to Know About PREVENT, the AHA's New Cardiovascular Disease Risk Calculator.
Larkin, Howard.
JAMA ; 331(4): 277-279, 2024 01 23.
Article in English | MEDLINE | ID: mdl-38150239

ABSTRACT

This Medical News article discusses the American Heart Association's new cardiovascular disease risk calculator, called PREVENT.


Subject(s)
Cardiovascular Diseases , Heart Disease Risk Factors , Risk Assessment , Humans , American Heart Association , Cardiovascular Diseases/prevention & control , United States
2.
Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.
Larkin, Howard.
JAMA ; 330(21): 2042-2043, 2023 12 05.
Article in English | MEDLINE | ID: mdl-37938824

ABSTRACT

This Medical News article discusses a recent American Heart Association presidential advisory on CKM syndrome that lays the groundwork for a new cardiovascular disease risk calculator.


Subject(s)
Cardiovascular Diseases , Kidney Diseases , Metabolic Syndrome , Humans , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Cardiovascular System , Heart , Kidney , Metabolic Syndrome/diagnosis , Metabolic Syndrome/epidemiology , United States/epidemiology , Kidney Diseases/diagnosis , Kidney Diseases/epidemiology
3.
Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723971

Subject(s)
Adaptive Immunity , COVID-19 , Humans , Adaptive Immunity/immunology , Antibodies, Viral/immunology , COVID-19/immunology , COVID-19/prevention & control , SARS-CoV-2 , COVID-19 Vaccines/immunology , COVID-19 Vaccines/therapeutic use , Reinfection/immunology , Reinfection/prevention & control , Vaccination
4.
High COVID-19 Rates Prompt Call for Better Nursing Home Protections.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723972

Subject(s)
COVID-19 , Infection Control , Nursing Homes , Humans , COVID-19/epidemiology , Nursing Homes/standards , Nursing Homes/statistics & numerical data , Skilled Nursing Facilities/standards , Skilled Nursing Facilities/statistics & numerical data , Infection Control/methods , Infection Control/standards , Infection Control/statistics & numerical data
5.
Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target.
Larkin, Howard.
JAMA ; 329(7): 532, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723975

Subject(s)
COVID-19 Drug Treatment , COVID-19 , Humans , COVID-19/therapy , Risk Factors , SARS-CoV-2 , Host-Pathogen Interactions
6.
Vasopressors or High-Volume IV Fluids Both Effective for Sepsis.
Larkin, Howard.
JAMA ; 329(7): 532, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723977

Subject(s)
Fluid Therapy , Sepsis , Vasoconstrictor Agents , Humans , Fluid Therapy/methods , Sepsis/drug therapy , Sepsis/therapy , Shock, Septic/drug therapy , Shock, Septic/therapy , Vasoconstrictor Agents/therapeutic use
7.
National Academies: Expand US Wastewater Disease Surveillance.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723984

Subject(s)
COVID-19 , SARS-CoV-2 , Wastewater-Based Epidemiological Monitoring , Wastewater , Humans , Academies and Institutes , COVID-19/prevention & control , COVID-19/virology , RNA, Viral/isolation & purification , SARS-CoV-2/isolation & purification , Wastewater/virology , United States
8.
Agent Slows Glioblastoma Tumors in Mice by Blocking Fat Metabolism.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723985

Subject(s)
Antimetabolites, Antineoplastic , Brain Neoplasms , Glioblastoma , Lipid Regulating Agents , Animals , Mice , Brain Neoplasms/drug therapy , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Glioblastoma/drug therapy , Glioblastoma/metabolism , Glioblastoma/pathology , Lipid Regulating Agents/therapeutic use , Antimetabolites, Antineoplastic/therapeutic use
9.
Both High- and Low-Dose Exercise Therapy Help Knee Osteoarthritis.
Larkin, Howard.
JAMA ; 329(7): 532, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723986

Subject(s)
Exercise Therapy , Osteoarthritis, Knee , Humans , Exercise Therapy/methods , Osteoarthritis, Knee/therapy , Pain Measurement
10.
New Report on Mpox Cases Leading Up to 2022 Global Outbreak.
Larkin, Howard.
JAMA ; 329(7): 531, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723992
11.
Nearly 500 000 in UK May Have Missed Blood Pressure Drugs.
Larkin, Howard.
JAMA ; 329(7): 531-532, 2023 02 21.
Article in English | MEDLINE | ID: mdl-36723993

Subject(s)
Antihypertensive Agents , Hypertension , Treatment Adherence and Compliance , Humans , Antihypertensive Agents/therapeutic use , Blood Pressure , Hypertension/drug therapy , Hypertension/epidemiology , United Kingdom/epidemiology , Treatment Adherence and Compliance/statistics & numerical data
12.
Substance Use, Mental Health Challenges Widespread in 2021.
Larkin, Howard D.
JAMA ; 329(5): 363, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652614

Subject(s)
Mental Disorders , Mental Health , Substance-Related Disorders , Humans , Mental Disorders/epidemiology , Mental Health/statistics & numerical data , Substance-Related Disorders/epidemiology , Substance-Related Disorders/psychology
13.
Gene Edited Tumor Cells Kill and Prevent Cancer in Mice.
Larkin, Howard D.
JAMA ; 329(5): 363, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652615

Subject(s)
CRISPR-Cas Systems , Gene Editing , Neoplasms , Animals , Mice , Gene Editing/methods , Neoplasms/genetics , Neoplasms/pathology , Neoplasms/prevention & control , Neoplasms/therapy
14.
Letters to Clinicians May Promote Better-Informed Opioid Prescribing.
Larkin, Howard D.
JAMA ; 329(5): 364, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652616

Subject(s)
Analgesics, Opioid , Correspondence as Topic , Practice Patterns, Physicians' , Humans , Analgesics, Opioid/therapeutic use , Chronic Pain/drug therapy , Opioid-Related Disorders/etiology , Opioid-Related Disorders/prevention & control , Practice Patterns, Physicians'/standards
15.
AAP Recommends Immediate, Intensive Treatment for Child Obesity.
Larkin, Howard D.
JAMA ; 329(5): 364, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652617

Subject(s)
Pediatric Obesity , Pediatrics , Child , Humans , Pediatric Obesity/therapy , Pediatrics/standards , Academies and Institutes/standards , United States , Practice Guidelines as Topic
16.
Sickle Cell Disease Gene Therapy Trial Paused.
Larkin, Howard D.
JAMA ; 329(5): 364, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652618

Subject(s)
Anemia, Sickle Cell , Clinical Trials as Topic , Genetic Therapy , Withholding Treatment , Humans , Anemia, Sickle Cell/therapy , Genetic Therapy/adverse effects
17.
Child Asthma Tied to Specific Urban Air Pollutants.
Larkin, Howard D.
JAMA ; 329(5): 363, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652621

Subject(s)
Air Pollutants , Air Pollution , Asthma , Child , Humans , Air Pollutants/adverse effects , Air Pollutants/analysis , Air Pollution/adverse effects , Air Pollution/analysis , Asthma/etiology , Environmental Exposure/adverse effects , Environmental Exposure/analysis , Particulate Matter/adverse effects , Particulate Matter/analysis , Urban Health , Urban Population
18.
NIH Pilots Telehealth Program for COVID-19.
Larkin, Howard D.
JAMA ; 329(5): 363-364, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652623

Subject(s)
COVID-19 , Telemedicine , Humans , SARS-CoV-2 , Pilot Projects , National Institutes of Health (U.S.) , United States
19.
Patients With Mild COVID-19 at Risk of Some Post-COVID-19 Condition Symptoms.
Larkin, Howard D.
JAMA ; 329(5): 364, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652624

Subject(s)
Post-Acute COVID-19 Syndrome , Humans , COVID-19/classification , COVID-19/complications , COVID-19/diagnosis , Risk Factors , Post-Acute COVID-19 Syndrome/diagnosis , Post-Acute COVID-19 Syndrome/etiology
20.
Lecanemab Gains FDA Approval for Early Alzheimer Disease.
Larkin, Howard D.
JAMA ; 329(5): 363, 2023 02 07.
Article in English | MEDLINE | ID: mdl-36652625

Subject(s)
Alzheimer Disease , Antibodies, Monoclonal, Humanized , Drug Approval , Humans , Alzheimer Disease/drug therapy , United States , United States Food and Drug Administration , Antibodies, Monoclonal, Humanized/therapeutic use
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL